Objective: Evaluate the clinical features in people with Hodgkin's lymphoma living with HIV (HIV-HL) during the combination ART (cART) era.
Design: Systematic review and meta-analysis.
Methods: The study was conducted in accordance with the recommendations of 2020 PRISMA and MOOSE statements.